BRPI0819975A2 - Processo para redução dos efeitos da doença de enxerto contra hospedeiros com o uso de células t reguladoras cd4+cd25+ expandidas ex vivo - Google Patents
Processo para redução dos efeitos da doença de enxerto contra hospedeiros com o uso de células t reguladoras cd4+cd25+ expandidas ex vivoInfo
- Publication number
- BRPI0819975A2 BRPI0819975A2 BRPI0819975-2A BRPI0819975A BRPI0819975A2 BR PI0819975 A2 BRPI0819975 A2 BR PI0819975A2 BR PI0819975 A BRPI0819975 A BR PI0819975A BR PI0819975 A2 BRPI0819975 A2 BR PI0819975A2
- Authority
- BR
- Brazil
- Prior art keywords
- regulatory
- cells
- reducing
- effects
- host disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/22—Immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/418—Antigens related to induction of tolerance to non-self
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99130107P | 2007-11-30 | 2007-11-30 | |
| US99234707P | 2007-12-05 | 2007-12-05 | |
| PCT/US2008/085117 WO2009073599A1 (en) | 2007-11-30 | 2008-12-01 | Process for reducing effects of graft versus host disease using ex vivo expanded cd4+cd25+ regulatory t cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0819975A2 true BRPI0819975A2 (pt) | 2015-06-16 |
Family
ID=40394411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0819975-2A BRPI0819975A2 (pt) | 2007-11-30 | 2008-12-01 | Processo para redução dos efeitos da doença de enxerto contra hospedeiros com o uso de células t reguladoras cd4+cd25+ expandidas ex vivo |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20090142317A1 (pt) |
| EP (1) | EP2225365A1 (pt) |
| JP (1) | JP2011505378A (pt) |
| KR (1) | KR20100094997A (pt) |
| CN (1) | CN101970643A (pt) |
| BR (1) | BRPI0819975A2 (pt) |
| CA (1) | CA2706458A1 (pt) |
| MX (1) | MX2010005863A (pt) |
| WO (1) | WO2009073599A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9314443B2 (en) | 2011-10-12 | 2016-04-19 | National Center For Child Health And Development | Enhancer of survival of transplanted organ |
| ES2675317T3 (es) * | 2012-03-02 | 2018-07-10 | The Regents Of The University Of California | Expansión de linfocitos T reguladores reactivos a aloantígeno |
| WO2013168876A1 (ko) * | 2012-05-11 | 2013-11-14 | 가톨릭대학교 산학협력단 | 이식 후 면역 상태를 모니터링 하는 키트 및 이를 이용한 면역 상태의 모니터링 방법 |
| EP2873417B1 (en) | 2012-07-13 | 2019-03-06 | SBI Pharmaceuticals Co., Ltd. | Immune tolerance inducer |
| WO2015014871A1 (en) * | 2013-07-31 | 2015-02-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and kits for identifying effector treg cells |
| CA2991077A1 (en) * | 2015-07-03 | 2017-01-12 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for obtaining regulatory t cells and uses thereof |
| EP3216861A1 (en) * | 2016-03-11 | 2017-09-13 | Fropharm GmbH | Immunoregulatory cells and methods for their production |
| CN107164324B (zh) * | 2017-07-17 | 2020-03-27 | 沃昕生物科技(深圳)有限公司 | 一种脐血Treg细胞的体外扩增方法 |
| SG11202010958YA (en) * | 2018-06-14 | 2020-12-30 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| EP4041870A1 (en) * | 2019-10-11 | 2022-08-17 | Kuopio Center For Gene and Cell Therapy OY | New regulatory macrophages and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050186207A1 (en) * | 2004-01-08 | 2005-08-25 | The Regents Of The University Of California | Regulatory T cells suppress autoimmunity |
| EP1812563B1 (en) * | 2004-10-29 | 2013-04-10 | Benaroya Research Institute at Virginia Mason | Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use |
| US8323969B2 (en) * | 2007-05-18 | 2012-12-04 | University Of Kansas | Preparation of regulatory T cells using ICAM-1 co-stimulation |
-
2008
- 2008-12-01 JP JP2010536216A patent/JP2011505378A/ja active Pending
- 2008-12-01 EP EP08855810A patent/EP2225365A1/en not_active Withdrawn
- 2008-12-01 BR BRPI0819975-2A patent/BRPI0819975A2/pt not_active IP Right Cessation
- 2008-12-01 WO PCT/US2008/085117 patent/WO2009073599A1/en not_active Ceased
- 2008-12-01 KR KR1020107013955A patent/KR20100094997A/ko not_active Withdrawn
- 2008-12-01 US US12/325,464 patent/US20090142317A1/en not_active Abandoned
- 2008-12-01 CN CN2008801186087A patent/CN101970643A/zh active Pending
- 2008-12-01 MX MX2010005863A patent/MX2010005863A/es unknown
- 2008-12-01 CA CA2706458A patent/CA2706458A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101970643A (zh) | 2011-02-09 |
| WO2009073599A1 (en) | 2009-06-11 |
| MX2010005863A (es) | 2010-06-23 |
| JP2011505378A (ja) | 2011-02-24 |
| EP2225365A1 (en) | 2010-09-08 |
| US20090142317A1 (en) | 2009-06-04 |
| CA2706458A1 (en) | 2009-06-11 |
| KR20100094997A (ko) | 2010-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0819975A2 (pt) | Processo para redução dos efeitos da doença de enxerto contra hospedeiros com o uso de células t reguladoras cd4+cd25+ expandidas ex vivo | |
| MX379016B (es) | Composiciones y metodos para tratar enfermedad de gaucher. | |
| BRPI1009981A2 (pt) | sistemas , métodos e composições para otimizar os enxertos enriquecidos de tecido e célula | |
| BRPI0922122A2 (pt) | composições e métodos para tratamento de doença celíaca. | |
| BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
| BRPI0718688A2 (pt) | Composições de baixa irritação e métodos para preparar as mesmas. | |
| BRPI0815979A2 (pt) | compostos e composições com inibidores de quinase, bem como uso dos mesmos | |
| BRPI0817306A2 (pt) | Implante para se ajustar dentro de um espaço intervertebral | |
| CR11731A (es) | Composiciones y procedimientos para su preparación y uso | |
| EP3135247C0 (en) | IMPLANTABLE TISSUE CONNECTOR | |
| BRPI0719849A2 (pt) | Método de imunização contra os quatro sorotipos da dengue | |
| BRPI0817437A2 (pt) | Implante cirúrgico com um recurso antirretrocesso | |
| EP2222344A4 (en) | VACCINATE COMPOSITIONS WITH DENDRITIC CELLS AND THEIR USE | |
| ES2397671T8 (es) | Procedimiento para preparar voriconazol | |
| EP2173353A4 (en) | Transplants | |
| FR2913196B1 (fr) | Implant oculaire accomodatif | |
| EA201000202A1 (ru) | Ингибиторы mpo для лечения болезни гентингтона и множественной системной атрофии | |
| BRPI0912292A2 (pt) | composições e métodos para o uso de células no tratamento do tecido cardíaco. | |
| CL2008001323A1 (es) | Compuestos derivados de triazolil aminopiridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer. | |
| BRPI0822349A2 (pt) | composições e métodos para tratar doenças lisossômicas | |
| BRPI0822946A2 (pt) | Derivado de carboxiamida, processo para preparação de derivado de carboxiamida, composição farmacêutica e uso do derivado de carboxiamida | |
| BRPI0910446A2 (pt) | rna modificado por lipídeo de flamento duplo tendo alto efeito de interferência de rna | |
| EP2320729A4 (en) | GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FROM THEREOF | |
| DK2142032T3 (da) | Kunstige negle indbefattende påføringsflig | |
| BRPI1013051A2 (pt) | composição imunogênica, uso de uma composição imunogênica, processo para fazer uma composição imunogênica, e, kit. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B15K | Others concerning applications: alteration of classification |
Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C12N 5/08; A61K 38/14. Ipc: A61K 39/00 (2006.01), A61K 38/14 (2006.01) Ipc: A61K 39/00 (2006.01), A61K 38/14 (2006.01) |